Michael Wang, MD¹, Javier Munoz, MD², Andre H. Goy, MD³, Frederick L. Locke, MD⁴, Caron A. Jacobson, MD^5*, Brian T. Hill, MD⁶, John M. Timmerman, MD⁷, Houston Holmes^8*, Samantha Jaglowski, MD, MPH⁹, Ian W. Flinn, MD, PhD¹⁰, Peter A. McSweeney, MD^11*, David B. Miklos, MD, PhD¹², John M. Pagel, MD, PhD¹³, Marie José Kersten, MD, PhD¹⁴, Noel Milpied^15*, Henry C.H. Fung, MD^16*, Max S. Topp, MD¹⁷, Roch Houot, MD, PhD^18*, Amer Beitinjaneh, MD, MPH, MSc^19*, Weimin Peng, PhD^20*, Lianqing Zheng, PhD^20*, John M. Rossi, MS^20*, Swaminathan Murugappan, MD, PhD^20*, Ioana Kloos, MD^20* and Patrick M. Reagan, MD²¹

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Banner MD Anderson Cancer Center, Gilbert, AZ
³John Theurer Cancer Center, Hackensack, NJ
⁴Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁵Dana-Farber Cancer Institute, Boston, MA
⁶Cleveland Clinic Foundation, Cleveland, OH
⁷David Geffen School of Medicine at UCLA, Los Angeles, CA
⁸Texas Oncology, Dallas, TX
⁹The Ohio State University, Comprehensive Cancer Center, Columbus, OH
¹⁰Sarah Cannon Research Institute, Nashville, TN
¹¹Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center, Denver, CO
¹²Stanford University School of Medicine, Stanford, CA
¹³Swedish Cancer Institute, Seattle, WA
¹⁴Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, on behalf of HOVON/LLPC, Amsterdam, Netherlands
¹⁵Hopital Haut Leveque, Pessac, France
¹⁶Fox Chase Cancer Center, Phladelphia
¹⁷Universitätsklinikum Würzburg, Würzburg, Germany
¹⁸CHU Rennes, Rennes, France
¹⁹University of Miami, Miami, FL
²⁰Kite, a Gilead Company, Santa Monica, CA
²¹University of Rochester School of Medicine, Rochester, NY

Amitkumar Mehta, MD¹, Marek Trněný, MD², Jan Walewski, MD^3*, Vincent Ribrag, MD⁴, Caroline Dartigeas, MD^5*, Jacob Haaber Christensen, MD, PhD^6*, Fabrizio Pane, MD⁷, Guillermo Rodríguez, MD^8*, Michal Taszner, MD^9*, Parameswaran Venugopal, MD¹⁰, Vittorio Ruggero Zilioli, MD^11*, Fred Zheng, MD^12*, Douglas J DeMarini, PhD^12*, Wei Jiang, PhD^12* and Pier Luigi Zinzani, MD¹³

¹UAB School of Medicine, Birmingham, AL
²Charles University General Hospital, Prague, Czech Republic
³Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
⁴Institut Gustave Roussy, Villejuif, France
⁵CHU Tours, Tours, France
⁶University of Southern Denmark, Odense, Denmark
⁷University of Naples Federico II, Naples, Italy
⁸Hospital Universitario Virgen del Rocío, Seville, Spain
⁹University of Gdańsk, Medical University of Gdansk, Gdansk, Poland
¹⁰Rush University, Chicago, IL
¹¹ASST Grande, Ospedale Metropolitano Niguarda, Milan, Italy
¹²Incyte Corporation, Wilmington, DE
¹³Institute of Hematology “Seràgnoli", University of Bologna, Bologna, Italy

Sarah E. Perry, MD, MSc¹, Derrick G. Lee, PhD^2*, Ciara L. Freeman, MSc, MBBChir³, Diego Villa, MD MPH³, Alina S. Gerrie, MD, MPH³, Pedro Farinha, MD, PhD^4*, Jeffrey W. Craig, MD, PhD^4*, Graham W. Slack, MD⁴, Joseph M. Connors, MD⁵, David W. Scott, MBChB, PhD³, Kerry J. Savage, BSc, MD, MSc³ and Laurie H. Sehn, MD, MPH⁶

¹BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada
²Department of Math & Statistics StFX University and BC Cancer Cancer Control Research, Vancouver, BC, Canada
³BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
⁴BC Cancer Centre for Lymphoid Cancer and Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
⁵BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Victoria, BC, Canada
⁶BC Cancer Centre for Lymphoid Cancer, University of British Columbia, vancouver, BC, Canada

Morton Coleman, MD, FACP^1*, David Jacob Andorsky, MD², Abdulraheem Yacoub, MD³, Jason M. Melear, MD⁴, Suzanne R. Fanning, DO⁵, Kathryn S. Kolibaba, MD⁶, Frederick Lansigan, MD⁷, Christopher M. Reynolds, MD^8*, Grzegorz S. Nowakowski, MD⁹, Mecide Gharibo, MD¹⁰, Erin Ahn, MS^11*, Ju Li, PhD^11*, Mathias J. Rummel, MD, PhD^12* and Jeff P Sharman, MD¹³

¹Clinical Research Alliance Inc., Weill Cornell Medicine, New York, NY
²Rocky Mountain Cancer Centers, US Oncology Research, Boulder, CO
³University of Kansas Cancer Center, Westwood, KS
⁴Texas Oncology, Austin, TX
⁵Prisma Health, US Oncology Research, Greenville, SC
⁶US Oncology Research, Vancouver, WA
⁷Dartmouth-Hitchcock Medical Center, Lebanon, NH
⁸IHA Hematology Oncology Consultants – Ann Arbor, Ypsilanti, MI
⁹Mayo Clinic, Rochester, MN
¹⁰Bristol-Myers Squibb, Princeton, NJ
¹¹Bristol-Myers Squibb Company, Princeton, NJ
¹²Justus-Liebig Universität, Giessen, Germany
¹³Willamette Valley Cancer Institute and Research Center, US Oncology Research, Eugene, OR

Lale Kostakoglu, MD, MPH^1*, Andrew Davies, MD, PhD^2*, Michael Herold³, Wolfgang Hiddemann⁴, Robert Marcus^5*, Judith Trotman, FRACP⁶, Andrea Knapp^7*, Federico Mattiello^7*, Tina G Nielsen^7*, Deniz Sahin^7*, Carol Ward^7* and Anas Younes⁸

¹University of Virginia, Charlottesville, VA
²Cancer Research UK Centre/Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom
³Helios-Klinikum, Erfurt, Germany
⁴Ludwig-Maximilians University Hospital, Munich, Germany
⁵HCA Healthcare, London, United Kingdom
⁶Concord Hospital, Concord, Australia
⁷F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁸Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York City, NY

Larry W. Kwak, MD, PhD¹, Juan Manuel Sancho, MD, PhD^2*, Seok-Goo Cho, M.D., Ph.D.^3,4*, Hideyuki Nakazawa, MD, PhD^5*, Junji Suzumiya, MD, PhD⁶, Gayane Tumyan^7*, Jin Seok Kim, MD, PhD^8*, Tobias F Menne, MD, PhD, FRCPath^9*, Jose Mario Mariz¹⁰, Nikolai Ilyin, DMSc, MD, PhD^11*, Wojciech Jurczak, MD, PhD¹², Aurelio Lopez Martínez, MD^13*, Olga Samoilova, MD^14*, Edvard Zhavrid, MD, PhD^15*, Eduardo Yanez Ruiz, MD^16*, Marek Trneny, MD, prof¹⁷, Leslie L. Popplewell, MD, FRCPA¹⁸, Michinori Ogura, MD, PhD¹⁹, Won Seog Kim, MD, PhD^20*, Sang Joon Lee, PhD^21*, Sung Hyun Kim, PhD^22*, Keum Young Ahn, PhD^22* and Christian Buske, MD²³

¹Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA
²Hematology Department, Hospital Germans Trias i Pujol / ICO-IJC, Pamplona, Spain
³Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁴Department of Haematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁵Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan
⁶Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan
⁷N.N.Blokhin Russian Cancer Research Center, Moscow, Russian Federation
⁸Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
⁹Northern Institute for Cancer Care, Newcastle University, Newcastle-upon-Tyne, United Kingdom
¹⁰Department of Onco-Hematology, Portuguese Institute of Oncology, Porto, Portugal
¹¹Russian Research Center for Radiology and Surgical Technologies, Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation
¹²Department of Hematology, Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland
¹³Department of Hematology, Hospital Arnau de Vilanova, Valencia, Spain
¹⁴Department of Hematology, Nizhniy Novgorod Region Clinical Hospital, Nizhniy Novgorod, Russian Federation
¹⁵N N Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Minsk, Belarus
¹⁶Universidad de la Frontera, Temuco, Chile
¹⁷First Dept. of Medicine- Hematology, Charles University General Hospital and First Faculty of Medicine, Praha 2, Czech Republic
¹⁸City of Hope Medical Center, Duarte, CA
¹⁹Department of Hematology and Oncology, Kasugai Municipal Hospital, Konan, Japan
²⁰Hematology and Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
²¹Celltrion, Inc., Incheon, Korea, Republic of (South)
²²Clinical Planning Department, Celltrion, Inc., Incheon, Korea, Republic of (South)
²³Comprehensive Cancer Center Ulm, Ulm, Germany

Michael Wang, MD¹, John M. Rossi, MS^2*, Javier Munoz, MD³, Andre H. Goy, MD⁴, Frederick L. Locke, MD⁵, Patrick M. Reagan, MD⁶, Caron A. Jacobson, MD⁷, Brian T. Hill, MD⁸, Houston Holmes^9*, Samantha Jaglowski, MD, MPH¹⁰, Weimin Peng, PhD^2*, Lianqing Zheng, PhD^2*, Xiang Fang, PhD^2*, Allen Xue, PhD^2*, Ioana Kloos, MD^2* and Adrian Bot, MD, PhD^2*

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Kite, a Gilead Company, Santa Monica, CA
³Banner MD Anderson Cancer Center, Gilbert, AZ
⁴John Theurer Cancer Center, Hackensack, NJ
⁵Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁶Wilmot Cancer Institute, University of Rochester Medical Center, Fairport, NY
⁷Dana-Farber Cancer Institute, Boston, MA
⁸Cleveland Clinic Foundation, Cleveland, OH
⁹Texas Oncology, Dallas, TX
¹⁰The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Ibrahim Tohidi-Esfahani, MBBS, FRACP, FRCPA^1,2, Andrew Warden^3*, Elena Malunis^4*, Peter Liburdi deNardis^4*, Javier Haurat^5,6*, Marita Black^5,6*, Stephen Opat, MBBS (Hons), FRACP, FRCPA^7,8, Shirley D'Sa, MD, FRCPath^9*, Marie José Kersten, MD, PhD¹⁰, Ruth Spearing, MD^11,12*, Maria Lia Palomba^13,14, Adam J Olszewski, MD^15,16, Carl Harrington^4*, Clare Scott, MBBS PhD FRACP^17,18* and Judith Trotman, FRACP^1,2

¹Haematology Department, Concord Repatriation General Hospital, Concord, Australia
²University of Sydney, Sydney, Australia
³WMozzies Australian Patient Support Group for Waldenström’s Macroglobulinemia, Sydney, Australia
⁴International Waldenström’s Macroglobulinemia Foundation, Sarasota, FL
⁵BioGrid Australia, Melbourne, Australia
⁶CART-Wheel.org, Melbourne, Australia
⁷Clinical Haematology, Monash Health and Monash University, Clayton, Australia
⁸Monash University, Clayton, VIC, Australia
⁹UCLH Centre for Waldenström’s Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁰Amsterdam University Medical Centers, University of Amsterdam;, Amsterdam, Netherlands
¹¹Canterbury District Health Board, Christchurch, NZL
¹²Christchurch Hospital, Christchurch, NZL
¹³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Department of Medicine, Weill Cornell Medical college, NY
¹⁵Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI
¹⁶Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI
¹⁷Department of Medical Oncology, Royal Melbourne Hospital, Melbourne, Australia
¹⁸Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Paolo Strati, MD¹, Felipe Samaniego, MD², Mariana Gallardo^3*, Mansoor Noorani^4*, F. B. B. Hagemeister, MD⁵, Jason R. Westin, MD⁶, Hun Ju Lee, MD², Maria Alma Rodriguez, MD^2*, Sattva S. Neelapu, MD², Jillian R. Gunther, MD, PhD^7*, Rashmi Kanagal-Shamanna, MD⁸, Francisco Vega, MD, PhD⁹, Nathan H Fowler, MD¹⁰, Chris R. Flowers, MD, MS¹¹ and Loretta J. Nastoupil, MD¹²

¹Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴UTMDACC, Houston
⁵Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, MD Anderson, Houston, TX
⁷Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
⁹Hematopathology, MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹MD Anderson Cancer Center, Houston, TX
¹²The University of Texas MD Anderson Cancer Center, Houston, TX

Preetesh Jain, MBBS, MD, DM, PhD¹, Guilin Tang, MD^2*, C. Cameron Yin, MD, PhD², Chi Young Ok, MD², Lucy Navsaria, MB BCh BAO^1*, Maria Badillo, MSN, RN, OCN, CCRP^1*, Wendy Chen^1*, Yijing Li, MS^1*, Yuxuan Che^1*, Yang Liu, PhD^1*, Onyeka Oriabure^1*, Graciela M. Nogueras González, MPH^3*, Jason Westin, MD¹, Loretta J. Nastoupil, MD³, Sairah Ahmed, MD⁴, Ranjit Nair^1*, Selvi Thirumurthi^5*, Shaoying Li, MD^6*, Rashmi Kanagal-Shamanna, MD⁷, Francisco Vega, MD, PhD⁸, Christopher Flowers, MD, MS¹ and Michael Wang, MD⁹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁵Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston
⁶Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
⁸Division of Hematopathology, Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX

Chan Yoon Cheah, MBBS¹, Nicholas Wickham, MBBS², Wojciech Jurczak^3*, Masa Lasica, MD^4*, Tomasz Wróbel, MD, PhD⁵, Jan Walewski, MD^6*, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA^7*, Katharine L Lewis, MBBS¹, Monika Dlugosz-Danecka, MD, PhD^8*, Krzysztof Giannopoulos, MD, PhD⁹, Hari P. Miskin, MSc^10*, Jian-Ping Tang, PhD^11*, Emmanuel Normant, PhD^11*, Alejandro D. Ricart, MD^11*, Owen A. O'Connor, MD, PhD¹⁰ and Constantine S. Tam, MBBS¹²

¹Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia
²Ashford Cancer Centre Research, Adelaide, Australia
³Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland
⁴St Vincent's Hospital, Melbourne, VIC, AUS
⁵Wrocław Medical University, Wrocław, Poland
⁶Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
⁷Department of Molecular Oncology and Cancer Immunology, Epworth HealthCare, East Melbourne, VIC, Australia
⁸Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁹Medical Univ. of Lublin, Lublin, Poland
¹⁰TG Therapeutics, Inc., New York, NY
¹¹TG Therapeutics Inc., New York, NY
¹²St. Vincent Hospital and University of Melbourne, Melbourne, Australia

Irl Brian Greenwell, MD¹, Jeffrey M. Switchenko, PhD, MS^2*, Kami J. Maddocks, MD³, Brad S. Kahl, MD⁴, Alexander F. M. Craig, MPhil⁵, Ash A. Alizadeh, MD, PhD⁶, Pamela B. Allen, MD, MSc⁷, Alena Lorretta Marbury, BS^8*, Alicia Escobar^8*, Kelly Valla, PharmD^9*, Miayea Williams^8*, Priya Parikh^8*, Danielle Roberts, PA-C^10*, Jessica J. Neely, PA-C^8*, Alexandra Palmer, NP-C^11*, Kristie A. Blum, MD¹⁰ and Jonathon B. Cohen, MD, MS¹²

¹Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
²Winship Cancer Institute, Biostatistics and Bioinformatics, Emory University, Atlanta, GA
³Division of Hematology, Department of Internal Medicine, Ohio State University Hospital, Columbus, OH
⁴Washington University School of Medicine in St. Louis, Saint Louis, MO
⁵Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
⁶Stanford University, Stanford, CA
⁷Winship Cancer Institute, Emory University, Assistant Professor, Department of Hematology and Medical Oncology, Attending Physician, Bone Marrow and Stem Cell Transplant Center, Emory University Winship Cancer Institute, Decatur, GA
⁸Emory University, Atlanta, GA
⁹Winship Cancer Institute, Emory University Hospital, Atlanta, GA
¹⁰Winship Cancer Institute, Emory University, Atlanta, GA
¹¹Winship Cancer Institute, Emroy University, Atlanta, GA
¹²Department of Hematology and Medical Oncology, Emory University, Atlanta, GA

Adrian Minson, MBBS^1,2*, Nada Hamad, MBBS, BSc, MSc, FRACP FRCPA^3,4, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA⁵, David Alan Westerman, MBBS, FRCPA, FRACP^2,6, David Ritchie, MB ChB, PhD, FRACP, FRCPA^2,6, Piers Blombery, MBBS^7,8*, John F. Seymour, MBBS^2,7, Constantine S. Tam, MBBS^2,6 and Michael Dickinson, MBBS, FRACP, FRCPA^2,7

¹Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Fitzroy North, VIC, Australia
²Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
³Faculty of Medicine, University of New South Wales, Sydney, Australia
⁴Department of Haematology, St Vincent's Hospital, Sydney, Australia
⁵Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
⁶Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
⁷Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
⁸University of Melbourne, Melbourne, Australia

Narendranath Epperla, MD, MS¹, Qiuhong Zhao, MS^2*, Sayan Mullick Chowdhury, PhD^3*, Tamara K. Moyo, MD^4*, Lauren Shea, MD^5*, Nishitha Reddy, MD, MSCI^6*, Julia Sheets, MD^7*, David M. Weiner, BA^8*, Praveen Ramakrishnan Geethakumari, MD, MS⁹, Malathi Kandarpa, PhD^10*, Ximena JordanBruno, MD^11*, Colin Thomas, MD^12*, Michael C. Churnetski^13*, Andrew Hsu, MD^14*, Joseph Maakaron, MD^15*, Paolo Caimi, MD¹⁶, Pallawi Torka, MD¹⁷, Celeste Bello, MD¹⁸, Cherie Tan, MD^19*, Kevin A. David, MD ¹⁹, Kathryn Lindsey, MD^20*, Irl Brian Greenwell, MD²¹, Murali Janakiram, MD²², Adam J Olszewski, MD¹⁴, Jonathon B. Cohen, MD, MS²³, Neil Palmisiano, MD, MS²⁴, Elvira Umyarova, MD²⁵, Ryan A. Wilcox, MD²⁶, Farrukh T Awan, MD⁹, Stefan K. Barta, MD, MRCP, MS²⁷, Natalie S Grover, MD²⁸, Nancy L. Bartlett, MD^29*, Yazeed Sawalha, MD², Beth A. Christian, MD³⁰, Alex F. Herrera, MD³¹ and Geoffrey Shouse, MD^31*

¹The Ohio State University James Comprehensive Cancer Center, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³Hematology, The Ohio State University, Columbus, OH
⁴Atrium Health, Charlotte, NC
⁵Washington University, St. Louis, MO
⁶Vanderbilt University Medical Center, Nashville, TN
⁷University of North Carolina, Chapel Hill, NC
⁸Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
⁹Division of Hematologic Malignancies and Stem Cell Transplantation, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
¹⁰University of Michigan Medical Center, Ann Arbor, MI
¹¹University of Vermont, Burlington, VT
¹²Thomas Jefferson University, Philadelphia, PA
¹³Winship Cancer Institute, Emory University Medical Center, Atlanta, GA
¹⁴Brown University, Providence, RI
¹⁵Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
¹⁶University Hospitals Seidman Cancer Center, Cleveland, OH
¹⁷Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
¹⁸H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁹Cancer Institute of New Jersey, New Brunswick, NJ
²⁰Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC
²¹Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
²²Division of Hematology, Oncology and Transplantation, University of Minnesota, Rochester, MN
²³Winship Cancer Institute, Emory University, Atlanta, GA
²⁴Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
²⁵The University of Vermont Medical Center, Burlington, VT
²⁶Rogel Cancer Center, University of Michigan, Ann Arbor, MI
²⁷Lymphoma Department, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²⁸Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²⁹Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
³⁰Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH
³¹City of Hope, Duarte, CA

Giovanni Manfredi Assanto, MD^1*, Costantino Riemma, MD^1*, Francesco Malaspina, MD^1*, Salvatore Perrone, MD^2*, Maria Lucia De Luca, MD^1*, Giorgia Annechini, MD^1*, Gianna Maria D'elia^1*, Maurizio Martelli, MD^1*, Robin Foà, MD³, Enrico Tiacci^4* and Alessandro Pulsoni, MD^1*

¹Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
²Hematology, Santa Maria Goretti Hospital, Latina, Italy
³Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy
⁴Institute of Hematology, University and Hospital of Perugia, Perugia, Italy

Junning Cao, MD^1*, Zhiming Li, MD, PhD^2*, Jianfeng Zhou, MD, PhD^3*, Dongmei Ji, MD, PhD^4*, Weina Shen, PhD^4*, Peng Sun, MD^2*, Yu Wang, MD^2*, Dengju Li, MD^3*, Zhenya Hong, MD, PhD^3*, Gaoxiang Wang, MD, PhD^3*, Xianlin Duan, MD^5*, Chen Yu, MD^5*, Yu Cai, PhD^5* and Weiguo Su, PhD^5*

¹Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China
²Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
³Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁴Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
⁵Hutchison MediPharma Limited, Shanghai, China

Jason T. Romancik, MD¹, Pamela B. Allen, MD, MSc², Edmund K. Waller, PhD, MD³, Zhengjia Chen, PhD^4*, Kelly Valla, PharmD^5*, Kaylan Dixon, BS^6*, David J. Reagan^6*, Amanda B. Colbert^6*, Cecilia Rosand, PA-C^7*, Alexandra Palmer, NP-C^8*, Christopher Flowers, MD, MS⁹ and Jonathon B. Cohen, MD, MS^10,11

¹Department of Hematology and Medical Oncology, Emory University - Winship Cancer Institute, Atlanta, GA
²Winship Cancer Institute, Emory University, Assistant Professor, Department of Hematology and Medical Oncology, Attending Physician, Bone Marrow and Stem Cell Transplant Center, Emory University Winship Cancer Institute, Decatur, GA
³Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
⁴Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA
⁵Winship Cancer Institute, Emory University Hospital, Atlanta, GA
⁶Winship Cancer Institute at Emory, Atlanta, GA
⁷Winship Cancer Institue, Emory University, Atlanta, GA
⁸Winship Cancer Institute, Emroy University, Atlanta, GA
⁹Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
¹¹Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA

Rahul Lakhotia, MD¹, Christopher Melani, MD¹, Jagan R. Muppidi, MD, PhD^1*, Stefania Pittaluga, MD, PhD², James D. Phelan, PhD^1*, Lydia L. Chou, CRNP^1*, Sarah Evans, RN^1*, Seth M. Steinberg, PhD^3*, William D. Figg, PhD^4*, Elaine S. Jaffe, MD², Louis M. Staudt, MD, PhD¹, Wyndham H. Wilson, MD, PhD¹ and Mark Roschewski, MD⁵

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Molecular Pharmacology Section, Genitourinary Malignancies Section, National Cancer Institute, Bethesda, MD
⁵Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Preetesh Jain, MBBS, MD, DM, PhD¹, Rashmi Kanagal-Shamanna, MD², Lucy Navsaria, MB BCh BAO^3*, Chi Young Ok, MD⁴, Holly Hill^3*, Dayoung Jung^3*, Graciela M. Nogueras González, MPH^5*, Hun Ju Lee, MD³, Ranjit Nair^3*, Sairah Ahmed, MD⁶, Raphael Eric Steiner, MD³, Guilin Tang, MD^4*, Shaoying Li, MD^7*, Keyur Patel, MD, PhD^8*, Selvi Thirumurthi^9*, Pan Tinsu^10*, Guofang Xu, MD^11*, Francisco Vega, MD, PhD¹², Christopher Flowers, MD, MS³ and Michael Wang, MD¹³

¹Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Biostatistics, UT MD Anderson Cancer Center, Houston
⁶Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁸University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston
¹⁰Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Division of Hematopathology, Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, TX
¹³Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX

Louise Bouard, MD in training^1*, Catherine Thieblemont², Krimo Bouabdallah, MD^3*, Thomas Gastinne, MD^4*, Anne Moreau, MD^5*, Sibylle Masse^6*, Rémy Gressin, MD^7*, Lucie Oberic, MD^8*, Alexis Caulier, MD^9*, Emmanuel Gyan, MD, PhD¹⁰, Victoria Cacheux^11*, Olivier Casasnovas^12*, Olivier Hermine¹³ and Steven Le Gouill, MD, PhD¹⁴

¹Clinical Hematology Nantes University Hospital, Nantes, France
²APHP, Hôpital Saint-Louis, Hemato-Oncology, Paris, France; Diderot University, Sorbonne Paris-Cité, Paris, France
³Department of Hematology, University Hospital of Bordeaux, Pessac, France
⁴Clinical Hematology, Nantes University Hospital, Nantes, France
⁵Pathology Department, Nantes University Hospital, Nantes, France
⁶Lysarc, Lyon, France
⁷Department of clinical hematology., Centre Hospitalier et Universitaire de Grenoble-Alpes, Grenoble, France
⁸Department of Hematology, Purpan University Hospital, Toulouse, France
⁹CHU Amiens Sud, Amiens Cedex 1, France, FRA
¹⁰Centre Hospitalier Universitaire, Service D'Hemaologie Et Therapie Cellulaire, Tours Cedex, France
¹¹CHU Estaing, Clermont Ferrand, FRA
¹²University Hospital F. Mitterand and INSERM UMR 1231, Dijon, France
¹³Hematology Department, AP-HP Hôpital Necker, University Paris Descartes, Paris, France
¹⁴Service d’hématologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France

Yuqin Song, MD, PhD^1*, Wei Xu, MD, PhD², Yongping Song, MD^3*, Lihong Liu, MD^4*, Song Lin^5*, Zhiming Li, MD, PhD^6*, Ting Liu, MD, PhD⁷, Shuhua Yi, MD^8*, Daobin Zhou, MD, PhD^9*, Mingzhi Zhang, MD^10*, Yu Hu, MD^11*, Jie Jin, MD, PhD¹², Huaqiang Zhu, MD^13*, Zhengguang Lu^13*, Renbin Zhao, PhD^13*, Zhixin Xu, MD, PhD^13* and Jun Zhu, BS¹

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
²Department of Hematology, Pukou CLL Center, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
³Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
⁴The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
⁵Neurosurgery Center, Beijing Tiantan Hospital , Capital Medical University, Beijing,, China
⁶Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁷Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
⁸National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
¹⁰Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
¹¹Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹²Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China
¹³Beijing InnoCare Pharma Tech Co., Ltd, Beijing, China

Saurabh Zanwar^1*, Jithma P. Abeykoon, MD², Stephen M. Ansell, MD, PhD², Morie Gertz³, Jonas Paludo, MD², Rebecca L. King, MD⁴, Rong He, MD⁴, Carrie A. Thompson, MD², Rahma M Warsame, MD², Grzegorz S. Nowakowski, MD², David J. Inwards, MD², Thomas E. Witzig, MD², Martha Q. Lacy, MD³, Wilson I Gonsalves, MD², Angela Dispenzieri, MD², David Dingli, MD, PhD³, Ronald S. Go, MD⁵, Thomas M. Habermann, MD², Robert A. Kyle, MD³, S. Vincent Rajkumar, MD³, Shaji K. Kumar, MD³ and Prashant Kapoor, MD³

¹Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Mayo Clinic Rochester, Division of Hematology, Rochester, MN
⁴Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁵Mayo Clinic Rochester, Division of Hematology, Onalaska, WI

Elizabeth Budde, MD PhD¹, Ajay K. Gopal, MD², Ian W. Flinn, MD, PhD³, Loretta J. Nastoupil, MD⁴, Michael S. Gordon, MD^5*, Ching-Fai Pang, PhD^6*, Bruce Keyt, PhD^7*, Steve Carroll, PhD^7*, Maya Leabman, PhD^7*, Genevive Hernandez, PhD^7*, Iris Sison^7*, Daniel Chen, MD, PhD⁷, Wayne Godfrey, MD⁷ and Philippe Armand, MD, PhD⁸

¹T Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²Seattle Cancer Care Alliance, Seattle, WA
³Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Premiere Oncology of Arizona, Scottsdale, AZ
⁶Phi Consulting Group, Bellevue, WA
⁷IGM Biosciences, Mountain View, CA
⁸Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

Caroline Weibull^1*, Björn E Wahlin, MD, PhD², Sandra Lockmer^3*, Gunilla Enblad^4,5*, Per-Ola Andersson, MD, PhD^6,7*, Eva Kimby, MD, PhD^8,9 and Karin E. Smedby, MD, PhD^3,10*

¹Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
²Karolinska Institutet, Department of Medicine, Huddinge, and Karolinska University Hospital, Unit for Hematology, Stockholm, Sweden
³Karolinska University Hospital, Stockholm, Sweden
⁴Dept of Oncology, Akademiska University Hospital, Uppsala, Sweden
⁵Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
⁶Gothenburg University, Sahlgrenska Academy, Gothenburg, Sweden
⁷Dept of Hematology, South Älvsborg Hospital, Borås, Sweden
⁸Hematology, Karolinska Institute, Stockholm, Sweden
⁹Karolinska Institute, Department of Medicine Huddinge and Karolinska University Hospital, Stockholm, Sweden
¹⁰Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Tanaya Shree, MD, PhD, BA¹, Michael S. Khodadoust, MD, PhD², Debra K. Czerwinski, BA¹, Matthew J. Frank, MD, PhD³, Sara Beygi, MD^4*, Steven R. Long, MD^5*, Brock Martin, MD^6* and Ronald Levy, MD⁷

¹Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA
²Division of Medical Oncology, Stanford University School of Medicine, Stanford, CA
³Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
⁴Divisions of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA
⁵Department of Pathology, University of California San Francisco, San Francisco, CA
⁶Department of Pathology, Stanford University, Stanford, CA
⁷Stanford Univ. School of Medicine, Stanford, CA

Gilles Salles, MD, PhD¹, Ka Lung Wu, MD, PhD², Sofya Kovalchuk, MD^3,4*, Santiago Mercadal, MD^5*, Annalisa Chiarenza, MD, PhD^6*, Ruth Pettengell, MD^7*, Elisabeth Vandenberghe, MD^8*, Paolo Corradini, MD^9*, Susana Carvalho, MD^10*, Christophe De Belder, MSc^11*, Rikisha Shah Gupta, MPH^12*, Anna van Troostenburg, MD^13*, Nishanthan Rajakumaraswamy, MD^14* and Heribert Ramroth, PhD^12*

¹Hospices Civils de Lyon, Université Claude Bernard, Lyon, France
²Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
³Azienda Ospedaliero Universitaria Careggi, Florence, Italy
⁴Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
⁵ICO-Hospital Duran i Reynals, Hospitalet De Llobregat, Spain
⁶AOU Policlinico, University of Catania, Division of Hematology, Catania, Italy
⁷Clinical Sciences, St. George's Hospital, London, United Kingdom
⁸Haematology Department, St. James Hospital, Dublin, Ireland
⁹Fondazione IRCCS Istituto Nazionale Dei Tumori & University of Milan, Milan, Italy
¹⁰Instituto Português de Oncologia, Lisbon, Portugal
¹¹Clinical Operations Late Phase, Gilead Sciences Europe, Ltd., London, United Kingdom
¹²Data Science and Biometrics/Epidemiology, Gilead Sciences, Ltd., London, United Kingdom
¹³Global Patient Safety, Gilead Sciences GmbH, Munich, Germany
¹⁴Clinical Research Oncology, Gilead Sciences, Inc., Foster City, CA

Jayasree Krishnan, MD^*, Victoria Nachar, PharmD^*, Bernard Lawrence Marini, PharmD^*, Anthony J. Perissinotti, PharmD^*, Tycel J. Phillips, MD, Mark S Kaminski, MD, Shannon A. Carty, MD and Ryan A. Wilcox, MD

Rogel Cancer Center, University of Michigan, Ann Arbor, MI

Paola Ghione, MD^1,2, Kurt S. Bantilan, MPH^2*, Erel Joffe, MD, MSc², M. Lia Palomba, MD³, Ariela Noy, MD³, Matthew J Matasar, MD, MS², Philip Caron, MD, PhD², Audrey Hamilton, MD^2*, Paul A. Hamlin, MD², Anita Kumar, MD⁴, Colette Owens, MD², Alison J. Moskowitz, MD², Lorenzo Falchi, MD², Gottfried von Keudell, MD, PhD², Ildefonso Rodriguez-Rivera, MD^2*, David J. Straus, MD², Steven M. Horwitz, MD², Ahmet Dogan, MD, PhD⁵ and Andrew D Zelenetz, MD, PhD²

¹Department of Medicine, Lymphoma Service, Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Medicine, Lymphoma Service, Memorial Sloan Kettering, Short Hills, NJ
⁵Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

Marc Maynadie, MD, PhD¹, Sophie Gauthier^2*, Morgane Mounier, PhD^3*, Côme Bommier^4*, Sebastien Orazio^5*, Hélène Rachou^6*, Alain Monnereau, MD, PhD^7*, Xavier Troussard, MD⁸ and Catherine Thieblemont, MD, PhD⁹

¹University of Burgundy, Registre des Hemopathies Malignes de Côte d'Or, Dijon, France
²INSERM U1231, Registre des Hémopathies Malignes de Côte d'Or, Dijon, France
³Registre des Hémopathies Malignes de Côte d'Or, Dijon, France
⁴Assistance Publique Hôpitaux De Paris, Saint Louis Hospital, Division of, Paris, FRA
⁵Registre des hémopathies malignes de Gironde, Bordeaux, France
⁶Institut Bergonié, Registre des Hémopathies Malignes de Gironde, Bordeaux, France
⁷EPICENE, Institut Bergonie, Bordeaux, France
⁸Department of Haematology, C.H.U. de Caen, Caen Cedex9, France
⁹Department of Hemato-Oncology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France

Nathan H Fowler, MD^1,2, Michael Dickinson, MBBS, FRACP, FRCPA³, Martin Dreyling, MD⁴, Joaquin Martinez-Lopez, MD^5*, Arne Kolstad, MD, PhD^6*, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA⁷, Monalisa Ghosh, MD⁸, Leslie L. Popplewell, MD, FACP⁹, Julio C. Chavez, MD¹⁰, Emmanuel Bachy, MD, PhD^11*, Koji Kato, MD, PhD¹², Hideo Harigae, MD, PhD¹³, Marie José Kersten, MD, PhD¹⁴, Charalambos Andreadis, MD¹⁵, Peter A. Riedell, MD¹⁶, P. Joy Ho, MB.BS. (Hons), D.Phil (Oxon), FRACP, FRCPA, FFSc(RCPA)¹⁷, Jose Antonio Pérez-Simón, MD^18*, Sarah J. Nagle, MD¹⁹, Loretta J. Nastoupil, MD²⁰, Bastian von Tresckow, MD^21,22*, Andres JM Ferreri, MD²³, Takanori Teshima, MD²⁴, Piers Patten, MD, PhD²⁵, Joseph P. McGuirk, DO²⁶, Andreas Petzer, MD²⁷, Fritz Offner, MD, PhD²⁸, Andreas Viardot, Professor Dr²⁹, Pier Luigi Zinzani, MD³⁰, Ram Malladi, MBBS(Lond), MRCP(UK), FRCPath^31*, Lida Bubuteishvili Pacaud, MD^32*, Alessandra Forcina, MD^33*, Aiesha Zia^33*, Stephen J. Schuster, MD³⁴ and Catherine Thieblemont, MD, PhD³⁵

¹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²BostonGene, Waltham, MA
³Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁴Medizinische Klinik III, LMU Klinikum, Munich, Germany
⁵Hospital 12 De Octubre, Complutense University, CNIO, Madrid, Spain
⁶Department of Oncology, Oslo University Hospital, Oslo, Norway
⁷Royal Brisbane and Women's Hospital, Brisbane, Australia
⁸Michigan Medicine University of Michigan, Ann Arbor, MI
⁹City of Hope, Duarte, CA
¹⁰Moffitt Cancer Center, Tampa, FL
¹¹Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
¹²Kyushu University Hospital, Fukuoka, Japan
¹³Tohoku University Hospital, Sendai, Japan
¹⁴Amsterdam University Medical Centers, University of Amsterdam;, Amsterdam, Netherlands
¹⁵Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
¹⁶University of Chicago Medical Center, Chicago, IL
¹⁷Royal Prince Alfred Hospital and University of Sydney, Camperdown, Australia
¹⁸Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CSIC / CIBERONC), Universidad de Sevilla, Sevilla, Spain
¹⁹Oregon Health and Science University, Portland, OR
²⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²¹Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
²²Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
²³IRCCS Ospedale San Raffaele, Milan, Italy
²⁴Hokkaido University Hospital, Sapporo, Japan
²⁵King’s College Hospital and King’s College London, London, United Kingdom
²⁶University of Kansas Hospital and Medical Center, Westwood, KS
²⁷Internal Medicine I, Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria
²⁸UZ Gent, Gent, Belgium
²⁹Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
³⁰Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
³¹Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
³²Novartis Pharmaceuticals Corporation, East Hanover, NJ
³³Novartis Pharma AG, Basel, Switzerland
³⁴University of Pennsylvania, Philadelphia, PA
³⁵Hôpital Saint-Louis, Paris, France